Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AXICABTAGENE CILOLEUCEL for Diffuse large b-cell lymphoma refractory: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 336 adverse event reports in the FDA FAERS database where AXICABTAGENE CILOLEUCEL was used for Diffuse large b-cell lymphoma refractory.

Most Reported Side Effects for AXICABTAGENE CILOLEUCEL

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 4,140 48.2% 718 1,880
Immune effector cell-associated neurotoxicity syndrome 1,821 21.2% 402 903
Neurotoxicity 1,327 15.4% 239 615
Pyrexia 859 10.0% 125 450
Death 756 8.8% 756 68
Disease progression 745 8.7% 326 137
Hypotension 398 4.6% 86 223
Neutropenia 391 4.6% 60 194
Confusional state 299 3.5% 38 176
Encephalopathy 292 3.4% 58 172
Diffuse large b-cell lymphoma 291 3.4% 157 73
Febrile neutropenia 282 3.3% 45 229
Fatigue 256 3.0% 15 85
Myelodysplastic syndrome 249 2.9% 113 27
Pancytopenia 239 2.8% 64 151

Other Indications for AXICABTAGENE CILOLEUCEL

Diffuse large b-cell lymphoma (3,482) Product used for unknown indication (1,953) B-cell lymphoma (695) Non-hodgkin's lymphoma (656) Follicular lymphoma (281) Lymphoma (170) Primary mediastinal large b-cell lymphoma (161) Diffuse large b-cell lymphoma recurrent (123) Diffuse large b-cell lymphoma stage iv (105) High-grade b-cell lymphoma (89)

Other Drugs Used for Diffuse large b-cell lymphoma refractory

RITUXIMAB (667) EPCORITAMAB-BYSP (353) BENDAMUSTINE (283) CYCLOPHOSPHAMIDE (226) POLATUZUMAB VEDOTIN (223) ETOPOSIDE (165) POLATUZUMAB VEDOTIN-PIIQ (158) GEMCITABINE (147) LENALIDOMIDE (143) DEXAMETHASONE (136)

Related Pages

AXICABTAGENE CILOLEUCEL Full Profile All Diffuse large b-cell lymphoma refractory Drugs AXICABTAGENE CILOLEUCEL Demographics AXICABTAGENE CILOLEUCEL Timeline